US FDA Commissioner Scott Gottlieb noted the agency's interest in receiving applications for derivatives of medical marijuana during a House appropriations hearing on FDA's proposed budget for fiscal year 2019.
Rep
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?